医学
Paper Review Records
全部论文审稿周期
18 篇有效样本 · 按发表日期由新到旧排列
审稿天数=录用日期-收稿日期;保留 PDF/DOI/网页源链接
Development and validation of a preoperative 18 F-PSMA-1007 PET/MR prognostic model for predicting biochemical recurrence in prostate cancer: a multicentre study
作者Jiajia Hu; Hangxing Chunyu; Yihong Yang; Yanyan Song; Chao Cheng; Hailang Tang; Xiaoyue Chen; Ran Cheng; Jun Dai; Hongping Meng; Changjing Zuo; Jun Zhao; Biao Li
作者单位1. Department of Nuclear Medicine & Institute for Medical Imaging Technology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 2. Department of Nuclear Medicine, Shanghai East Hospital, School of Medicine, Tongji University, Shanghai, China; 3. Department of Biostatistics, Institute of Clinical Medicine, Shanghai Jiao-Tong University School of Medicine, Shanghai, China; 4. Department of Nuclear Medicine, Changhai Hospital, Navy Military Medical University, Shanghai, China; 5. Department of Ultrasound, Jiading North Hospital, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China; 6. Department of Urology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China
Tri-modal PSMA PET/CT-MRI-US fusion biopsy for clinically significant prostate cancer: a prospective paired diagnostic study
作者Chen Huang; Lichen Jin; Yizhang Sun; Menglin Wu; Xuefeng Zhang; Xiaofeng Xu; Xuefeng He; Feng Qiu; Ximing Wang; Lingchuan Guo; Renpeng Huang; Jihui Li; Shengming Deng; Yuxin Lin; Xuedong Wei; Bin Zhang; Yuhua Huang
作者单位1. Department of Urology, The First Affiliated Hospital of Soochow University, Suzhou, China; 2. School of Computer Science and Technology, Nanjing Tech University, Nanjing, China; 3. Carbon Medical Device Ltd, Shenzhen, China; 4. Department of Radiology, The First Affiliated Hospital of Soochow University, Suzhou, China; 5. Department of Pathology, The First Affiliated Hospital of Soochow University, Suzhou, China; 6. Department of Nuclear Medicine, The First Affiliated Hospital of Soochow University, Suzhou, China
Correlation of 68 Ga-PSMA-11 PET/CT biodistribution with PSMA expression by immunohistochemistry in patients with HCC: A pilot prospective monocentric study
作者L. Vetrone; E. Prosperi; E. Prosperi; F. Vasuri; A. Degiovanni; V. Allegri; P. Castellucci; L. Zanoni; Cristina Nanni; M. Renzulli; V. Lucidi; A. Cattabriga; C. Malizia; M. Ravaioli; M. Cescon; S. Fanti; A. Farolfi
作者单位1. Nuclear Medicine, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 2. Department of Hepatobiliary Surgery and Liver Transplant, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 3. Pathology Unit, Santa Maria delle Croci Ravenna Hospital, Ravenna, Italy; 4. Pathology Unit, IRCCS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 5. Department of Medical and Surgical Sciences (DIMEC), Bologna University, Bologna, Italy; 6. Nuclear Medicine, AST Pesaro Urbino, Pesaro, Italy; 7. Department of Radiology, IRCSS Azienda Ospedaliero-Universitaria di Bologna, Bologna, Italy; 8. Nuclear Medicine, Alma Mater Studiorum University of Bologna, Bologna, Italy
Prognostic value and diagnostic performance of nectin-4-targeted [ 68 Ga]Ga-FZ-NR-1 PET/CT versus [ 18 F]FDG in recurrent or metastatic triple-negative breast cancer
作者Ye Li; Yuyun Sun; Li Sun; Dongliang Wang; Xiaoyu Pan; Xiaoping Xu; Shaoli Song
作者单位1. Department of Nuclear Medicine, Fudan University Shanghai Cancer Center, Shanghai, China; 2. Department of Oncology, Shanghai Medical College, Fudan University, Shanghai, China; 3. Center for Biomedical Imaging, Fudan University, Shanghai, China; 4. Shanghai Engineering Research Center of Molecular Imaging Probes, Shanghai, China
Practices and barriers in PET/CT use for critically ill patients: an international survey
作者Camilla Genovese; Jean-François Timsit; Michael Thy
作者单位1. Department of Infectious Diseases, Ospedale Luigi Sacco, Milan, Italy; 2. Infectious Diseases Intensive Care Unit, Bichat-Claude Bernard University Hospital, AP-HP, Université Paris Cité, Paris, France; 3. Université Paris Cité and Université Sorbonne Paris Nord, INSERM, UMR1137, IAME, Paris, France; 4. UMR 1343, GEME, Pharmacologie et évaluation des thérapeutiques chez l’enfant et la femme enceinte, INSERM, Université Paris Cité, Paris, France
Radium-223 decreases PD-L1 expression in bone metastases: A study with [ 89 Zr]Zr-atezolizumab PET and immunohistological correlation
作者Sui Wai Ling; Anouk de Jong; Mark Gorris; Marcel Segbers; Laura Graven; Marjolein van Driel; Geert van Leenders; Khrystany Isebia; Marjolijn Lub – de Hooge; Paul Hamberg; Niven Mehra; Mandy van Brakel; Ronald de Wit; Reno Debets; Elisabeth de Vries; Tessa Brabander; Jolanda de Vries; Astrid van der Veldt
作者单位1. Department of Radiology and Nuclear Medicine, Erasmus MC, Rotterdam, the Netherlands; 2. Department of Medical Oncology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 3. Department of Medical BioSciences, Radboudumc, Nijmegen, the Netherlands; 4. Department of Internal Medicine, Erasmus MC, Rotterdam, the Netherlands; 5. Department of Pathology, Erasmus MC Cancer Institute, Rotterdam, the Netherlands; 6. Department of Clinical Pharmacy and Pharmacology, UMC Groningen, University of Groningen, Groningen, the Netherlands; 7. Department of Internal Medicine, Franciscus Gasthuis and Vlietland Hospital, Rotterdam, the Netherlands; 8. Department of Medical Oncology, Radboud UMC, Nijmegen, the Netherlands; 9. Department of Medical Oncology, UMC Groningen, University of Groningen, Groningen, the Netherlands
Baseline serum carcinoembryonic antigen (CEA) is an independent prognostic biomarker for metastatic castration-resistant prostate cancer (mCRPC) patients receiving 177Lu-PSMA therapy
作者Emilio Francesco Giunta; Irene Marini; Ilaria Grassi; Silvia Nicolini; Flavia Foca; Monica Celli; Paola Caroli; Anna Sarnelli; Nicole Brighi; Giuseppe Schepisi; Manuela Monti; Ugo De Giorgi; Cristian Lolli; Maddalena Sansovini
作者单位1. Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 2. Department of Nuclear Medicine, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 3. Unit of Biostatistics and Clinical Trials, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) “Dino Amadori”, Meldola, Italy; 4. Department of Experimental Medicine, University of Salento, Lecce, Italy
APOE4-dependent cholinergic/dopaminergic contributions to clinical symptoms across Alzheimer’s disease spectrum: A retrospective observational study
作者Sungwoo Kang; Seun Jeon; Donggeon Lee; Hanbi Lee; Su-Hee Jeon; Minsun Choi; Young-gun Lee; Na-Young Shin; Mijin Yun; Byoung Seok Ye
作者单位1. Department of Neurology, Hanyang University College of Medicine, Seoul, Republic of Korea; 2. Metabolism-Dementia Research Institute, Yonsei University College of Medicine, Seoul, Republic of Korea; 3. Department of Neurology, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Republic of Korea; 4. Department of Radiology, Yonsei University College of Medicine, Seoul, Republic of Korea; 5. Department of Nuclear Medicine, Yonsei University College of Medicine, Seoul, Republic of Korea; 6. Department of Neurology, Yonsei University College of Medicine, Seoul, Republic of Korea
The effects of use of medications on striatal dopamine transporter binding assessed by [ 123 I]I-FP-CIT SPECT in patients with Parkinson’s disease from the PPMI cohort
作者Abdallah Nour Ali; Ilham Malik; Jan Booij; Youssef Chahid
作者单位1. Department of Radiology and Nuclear Medicine, University of Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands; 2. Department of Pharmacy, University of Amsterdam, Amsterdam UMC, Amsterdam, The Netherlands
Whole-body 18 F-FDG PET reveals glycemic state-dependent reorganization of directed inter-organ metabolic networks
作者Xuetong Tao; Runxiang Huang; Heng Jiang; Qian Sun; Yong Xiao; Zhan Li; Ning Ma; Xiaohua Lin; Guanghua Wen; Hairong Zheng; Dong Liang; Na Zhang; Mengjie Dong; Zhanli Hu
作者单位1. Lauterbur Research Center for Biomedical Imaging, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; 2. Key Laboratory of Biomedical Imaging Science and System, State Key Laboratory of Biomedical Imaging Science and System, Chinese Academy of Sciences, Shenzhen, China; 3. Research Center for Medical AI, Shenzhen Institute of Advanced Technology, Chinese Academy of Sciences, Shenzhen, China; 4. Department of Nuclear Medicine, Peking University Shenzhen Hospital, Shenzhen, China; 5. Medical Imaging Center, Shenzhen Exit - Entry Frontier Inspection Station General Hospital, Shenzhen, China; 6. Department of Nuclear Medicine, Shenzhen Longhua District Central Hospital, Shenzhen, China
Expert Matching · Case Demo
把投稿要求,转成可验证的期刊方案
说清专业、时限和作者背景,CrushSCI 结合真实审稿样本,给出拟题方向、期刊初筛与周期判断。